BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17505146)

  • 1. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
    Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
    Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
    Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis.
    Hasegawa M; Nakoshi Y; Iino T; Sudo A; Segawa T; Maeda M; Yoshida T; Uchida A
    J Rheumatol; 2009 Feb; 36(2):240-5. PubMed ID: 19208558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased vitreal hyaluronan levels with aging.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
    Er H; Doğanay S; Ozerol E; Yürekli M
    Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous leptin levels in retinal disease.
    Maberley D; Cui JZ; Matsubara JA
    Eye (Lond); 2006 Jul; 20(7):801-4. PubMed ID: 16052255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
    Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
    Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
    Yoneda S; Hara H; Hirata A; Fukushima M; Inomata Y; Tanihara H
    Jpn J Ophthalmol; 2005; 49(2):106-8. PubMed ID: 15838725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Takeuchi M; Kezuka T; Iwasaki T; Goto H
    Diabet Med; 2008 Jul; 25(7):875-7. PubMed ID: 18644076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
    Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
    Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases.
    Kocak N; Alacacioglu I; Kaynak S; Ozcan MA; Celik O; Yuksel F; Piskin O; Oner H; Saatci AO; Ergin M
    Ann Ophthalmol (Skokie); 2010; 42 Spec No():10-4. PubMed ID: 21138144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy.
    Hara H; Oh-hashi K; Yoneda S; Shimazawa M; Inatani M; Tanihara H; Kiuchi K
    Mol Vis; 2006 Aug; 12():977-82. PubMed ID: 16943769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis.
    Cho S; Ahn YS; Choi YS; Seo SK; Nam A; Kim HY; Kim JH; Park KH; Cho DJ; Lee BS
    Am J Reprod Immunol; 2009 Apr; 61(4):286-93. PubMed ID: 19260859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.